Neurocrine Biosciences, Inc. News
All the news that matters to Neurocrine Biosciences, Inc.
Neurocrine Presents Real-World Data Mapping Evolving Impact Of Congenital Adrenal Hyperplasia
www.nasdaq.com | 14:11 Fri 16 Oct 2026
Read More →
NBIX October 2027 Options Begin Trading
www.nasdaq.com | 15:46 Wed 14 Oct 2026
Read More →
Neurocrine Biosciences to Present Research Advancing Understanding of Prader-Willi Syndrome and Real-World Experience with VYKAT® XR (diazoxide choline) at Foundation for Prader-Willi Research Symposium & Family Conference
finance.yahoo.com | 13:30 Wed 30 Sept 2026
Read More →
Neurocrine Biosciences Reappoints Eiry Roberts As CMO, Keswani Departs
www.nasdaq.com | 08:52 Tue 29 Sept 2026
Read More →
Neurocrine Biosciences Appoints Eiry W. Roberts, M.D., as Chief Medical Officer
finance.yahoo.com | 21:05 Mon 28 Sept 2026
Read More →
NEUROCRINE BIOSCIENCES INC has a director or officer change
SEC EDGAR | 01:00 Mon 28 Sept 2026
Read More →